Trial Profile
A phase II study of bortezomib in combination with dexamethasone in patients with relapsed Hodgkin's lymphoma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 24 Jul 2007
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 29 Oct 2005 New trial record.